Haleon PLC’s Centrum Silver May Slow Biological Aging, Nature Medicine Study Finds
Haleon’s Centrum Silver multivitamin showed a slight slowdown in biological aging markers among older adults, according to an ancillary analysis from the COSMOS trial, detailed in a Nature Medicine paper published Monday. The findings land as a scientific boost for the British consumer health group’s flagship brand. Timing counts for Haleon. Back on Feb. 25, the company set its sights on 2026 organic revenue growth between 3% and 5% — that’s excluding currency effects and recent acquisitions — after soft U.S. demand and aggressive price moves from competitors took a bite out of sales. “The squeeze is apparent even in over-the-counter medicines,” noted Chris Beckett at Quilter Cheviot.